| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.07B | $1.04B | $1.12B |
| YoY Revenue Growth % | +2.5% | -6.6% | — |
| Gross Profit | $232.0M | $203.0M | — |
| Gross Margin % | 21.7% | 19.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | -$7.0M | $4.0M |
| Operating Margin % | 0.0% | -0.7% | 0.4% |
| Net Income (GAAP) | -$128.0M | $102.0M | $80.0M |
| EBITDA (Normalized) | $27.2M | $37.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $480.0M | -$7.0M | $38.0M |
| Capital Expenditures (CapEx) | $34.0M | $56.0M | — |
| Free Cash Flow (FCF) | $446.0M | -$63.0M | $38.0M |
| FCF Margin % | 41.7% | -6.0% | 3.4% |
| Return on Invested Capital (ROIC %) | 0.0% | -0.6% | — |
| Cash & Short-Term Equivalents | $337.0M | $201.0M | — |
| Total Debt (Short + Long Term) | $208.0M | $466.0M | — |
| Total Stockholders' Equity | $614.0M | $641.0M | — |